CD8A and cancer: Clinical investigations have shown that tumor immune cell infiltration levels correlate with clinical outcomes in many cancers; remarkably, tumor infiltration by CD8 + T cells (“hot tumors”) is frequently associated with improved overall patient prognosis and response to treatment [16].